Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination Scarring

The World Health Organization recommends Mycobacterium bovis BCG vaccination in areas of high tuberculosis prevalence. BCG's clinical and immune effects, not necessarily Mycobacterium tuberculosis specific, are unclear. BCG vaccine scarring often is used as a surrogate marker of vaccination or of ef...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Jason, Janine, Archibald, Lennox K., Nwanyanwu, Okey C., Kazembe, Peter N., Chatt, Julie A., Norton, Elizabeth, Dobbie, Hamish, Jarvis, William R.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Microbial Immunity and Vaccines
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC130324/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12379697/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.11.6188-6195.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!